Navigation Links
Halt Uterine Fibroid Study Attracts National Media Attention
Date:2/1/2010

LIVERMORE, Calif., Feb. 1 /PRNewswire/ -- The Wall Street Journal, CBS, and other popular news outlets have recently featured headline stories about a clinical study that is recruiting patients suffering with uterine fibroids.  "We're not at all surprised by the attention this study is getting from the media," said Russ DeLonzor, President and Chief Operating Officer of Halt Medical, Inc., a medical technology company headquartered near San Francisco.  Fibroids are benign tumors of the uterus that cause serious, debilitating symptoms including heavy menstrual bleeding, severe cramping, urinary problems, and painful intercourse. Currently the only cure that the gynecologist can offer to patients with fibroids involves major surgery.  "Each year nearly 250,000 women in the US undergo radical surgery to remove their entire uterus rather than to continue suffering with their fibroid symptoms," according to Mr. DeLonzor.  About 8 million women have fibroids, or leiomyomas of the uterus.  "So many lives are impacted in some way by fibroids.  It's no surprise that a clinical study of an outpatient procedure which targets the fibroids while sparing the uterus would gain such widespread attention from the media."   Details of who may qualify for the Halt Uterine Fibroid Study and participating clinical sites are available through the National Institutes of Health at:  clinicaltrials.gov/ct2/show/NCT00874029

SOURCE Halt Medical, Inc.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
2. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
3. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
4. UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed
5. Major surgery no longer needed for the removal of uterine fibroids
6. Scientists ID Uterine Muscle Switch for Contractions
7. Black women with uterine cancers more likely to die than white patients
8. Gene Variant Raises Risk of Uterine Fibroids
9. Prominent Chicago Gynecologists Launch Treatment Project To Raise Awareness Among African American Women of Non-Invasive Ultrasound Uterine Fibroid Procedure
10. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
11. Chamberlain Group Announces New Uterine Robotic Surgery Training Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Rosa, California (PRWEB) , ... May 23, 2017 ... ... health management (PHM) technology and a 2017 Best in KLAS category winner, has ... advantageous market position to extend and enhance its technology platform and product offerings,” ...
(Date:5/23/2017)... Newport Beach, CA (PRWEB) , ... May 23, 2017 , ... ... Capital Partners was honored to serve earlier this month as a Guest Speaker and ... by the British Royal Family and Common Purpose. , Walter Schindler ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... By all ... underway in Sonoma County. While officials call for diligence, asking homeowners to scout for ... at potential health concerns. Along with the annoying buzz of mosquitos is the buzz ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech ... in the modern ART laboratory, to provide hands-on training utilizing cutting-edge equipment at ... NextGen LifeLabs, a MedTech Group Purchasing vendor , will provide specialized equipment ...
(Date:5/23/2017)... ... ... New patients from Charleston, SC, are now welcome to receive a full mouth ... or without a referral. A full mouth reconstruction can transform the appearance of the ... SC. Those who suffer from gum disease, misaligned teeth or jaw pain can also ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
(Date:5/10/2017)... -- Radiology has become the number one diagnostic tool ... to the number one ranking as a result.  More ... as the most complete and reliable method for clinical ... pain an MRI may confirm a suspected herniated disc ... entirely different treatment protocols.  In these circumstances, patients need ...
Breaking Medicine Technology: